Key terms

About MDXG

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MDXG news

Mar 28 8:55am ET MiMedx Group (MDXG) Receives a Buy from Northland Securities by TipRanks Mar 28 7:50am ET Analysts Conflicted on These Healthcare Names: Cellectar Biosciences (CLRB), MiMedx Group (MDXG) and Marinus (MRNS) by TipRanks Mar 27 8:15am ET MiMedx provides update on AXIOFILL Request for Designation from FDA by TipRanks Mar 21 8:25am ET Northland Securities Keeps Their Buy Rating on MiMedx Group (MDXG) by TipRanks Mar 20 8:50am ET Analysts Conflicted on These Healthcare Names: Diamedica Therapeutics (DMAC), Design Therapeutics (DSGN) and MiMedx Group (MDXG) by TipRanks Mar 20 7:08am ET TELA Bio anounces sale of distribution rights for wound care product by TipRanks Mar 20 7:06am ET MiMedx enters agreement with TELA Bio for fibrillar collagen wound dressing by TipRanks Mar 13 8:15am ET MiMedx launches MiMedx Connect platform by TipRanks Mar 07 8:12am ET MiMedx initiated with a Buy at Lake Street by TipRanks Mar 04 8:11am ET MiMedx appoints two new independent directors by TipRanks Mar 01 7:31am ET MiMedx price target raised to $14 from $13 at Mizuho by TipRanks Feb 29 6:29am ET MiMedx Group: Strong Q4 Performance and Promising Growth Prospects Justify Buy Rating by TipRanks Feb 28 7:36pm ET MiMedx sees Fy24 adjusted EBITDA as percent of sales above 20% by TipRanks Feb 28 4:43pm ET MiMedx Group Q4 and Full-Year 2023 Performance Review by TipRanks Feb 28 4:14pm ET MiMedx reports Q4 EPS 4c, consensus 7c by TipRanks Feb 26 9:07am ET MiMedx Group (MDXG) Receives a Buy from Craig-Hallum by TipRanks Feb 12 8:40am ET Analysts Are Bullish on Top Healthcare Stocks: Zoetis (ZTS), MiMedx Group (MDXG) by TipRanks Feb 07 4:55am ET MiMedx management to meet with Craig Hallum by TipRanks Jan 31 9:13am ET MiMedx management to meet with Craig Hallum by TipRanks Jan 23 9:28am ET Northland Securities Sticks to Its Buy Rating for MiMedx Group (MDXG) by TipRanks Jan 23 8:50am ET Analysts’ Top Healthcare Picks: ClearPoint Neuro (CLPT), Semler Scientific (SMLR) by TipRanks Jan 22 8:05am ET MiMedx announces new senior secured credit facilities, debt refinancing by TipRanks Jan 05 9:15am ET Northland Securities Sticks to Their Buy Rating for MiMedx Group (MDXG) by TipRanks Jan 05 9:08am ET MiMedx named a ‘2024 Top Pick’ at Northland by TipRanks Jan 02 10:01am ET Analysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART) by TipRanks

No recent press releases are available for MDXG

MDXG Financials

1-year income & revenue

Key terms

MDXG Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MDXG Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming